Infectious blood or culture-grown virus: A comparison of bluetongue virus challenge models

Veterinary Microbiology

Volumn 146, Issue 1-2, 2010, Pages 150-154

  Eschbaumer, Michael ^a   Wäckerlin, Regula ^a   Rudolf, Miriam ^a   Keller, Markus ^a   König, Patricia ^a   Zemke, Johanna ^a   Hoffmann, Bernd ^a   Beer, Martin ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Bluetongue virus serotype 8; Challenge model; Clinical disease; Mice; Sheep; Viraemia

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOODSTREAM INFECTION; BLUETONGUE ORBIVIRUS; CONTROLLED STUDY; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHEEP; VIREMIA; VIROGENESIS; VIRUS CULTURE; VIRUS VIRULENCE;

ANIMALS; BLUETONGUE; BLUETONGUE VIRUS; BODY TEMPERATURE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SHEEP; VIRAL VACCINES; VIREMIA;

ANIMALIA; BLUETONGUE VIRUS; BLUETONGUE VIRUS 8; MUS; OVIS ARIES;

EID: 78049279270     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2010.05.004     Document Type: Article

References (29)

1. Alpar H.O., Bramwell V., Veronesi E., Darpel K., Pastoret P.P., Mertens P. Bluetongue virus vaccines past and present. Bluetongue 2009, Elsevier Academic Press, London, United Kingdom. P. Mellor, M. Baylis, P. Mertens (Eds.).
2. Batten C.A., Maan S., Shaw A.E., Maan N.S., Mertens P.P. A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment. Virus Res. 2008, 137:56-63.
3. Boone J.D., Balasuriya U.B., Karaca K., Audonnet J.C., Yao J., He L., Nordgren R., Monaco F., Savini G., Gardner I.A., Maclachlan N.J. Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. Vaccine 2007, 25:672-678.
4. Calvo-Pinilla E., Rodríguez-Calvo T., Anguita J., Sevilla N., Ortego J. Establishment of a bluetongue virus infection model in mice that are deficient in the alpha/beta interferon receptor. PLoS One 2009, 4:e5171.
5. Clavijo A., Heckert R.A., Dulac G.C., Afshar A. Isolation and identification of bluetongue virus. J. Virol. Methods 2000, 87:13-23.
6. Conraths F.J., Gethmann J.M., Staubach C., Mettenleiter T.C., Beer M., Hoffmann B. Epidemiology of bluetongue virus serotype 8, Germany. Emerg. Infect. Dis. 2009, 15:433-435.
7. Dal Pozzo F., De Clercq K., Guyot H., Vandemeulebroucke E., Sarradin P., Vandenbussche F., Thiry E., Saegerman C. Experimental reproduction of bluetongue virus serotype 8 clinical disease in calves. Vet. Microbiol. 2009, 136:352-358.
8. Darpel K.E., Batten C.A., Veronesi E., Shaw A.E., Anthony S., Bachanek-Bankowska K., Kgosana L., Bin-Tarif A., Carpenter S., Müller-Doblies U.U., Takamatsu H.H., Mellor P.S., Mertens P.P., Oura C.A. Clinical signs and pathology shown by British sheep and cattle infected with bluetongue virus serotype 8 derived from the 2006 outbreak in northern Europe. Vet. Rec. 2007, 161:253-261.
9. De Clercq K., Vandenbussche F., Vandemeulebroucke E., Vanbinst T., De Leeuw I., Verheyden B., Goris N., Mintiens K., Meroc E., Herr C., Hooybergs J., Houdart P., Sustronck B., De Deken R., Maquet G., Bughin J., Saulmont M., Lebrun M., Bertels G., Miry C. Transplacental bluetongue infection in cattle. Vet. Rec. 2008, 162:564.
10. Di Emidio B., Nicolussi P., Patta C., Ronchi G.F., Monaco F., Savini G., Ciarelli A., Caporale V. Efficacy and safety studies on an inactivated vaccine against bluetongue virus serotype 2. Vet. Ital. 2004, 40:640-644.
11. Dungu B.K., Louw I., Potgieter C., von Teichman B.F. Attenuated live bluetongue virus 8 vaccine protects sheep from challenge with the European BTV-8. Open Vet. Sci. J. 2008, 2:130-133.
12. EMEA Guideline on Requirements for an Authorisation Under Exceptional Circumstances for Vaccines for Emergency Use Against Bluetongue (EMEA/CVMP/IWP/220193/2008) 2008, European Medicines Agency Committee for Medicinal Products for Veterinary Use, London, United Kingdom.
13. Eschbaumer M., Hoffmann B., König P., Teifke J.P., Gethmann J.M., Conraths F.J., Probst C., Mettenleiter T.C., Beer M. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep. Vaccine 2009, 27:4169-4175.
14. Ferrari G., De Liberato C., Scavia G., Lorenzetti R., Zini M., Farina F., Magliano A., Cardeti G., Scholl F., Guidoni M., Scicluna M.T., Amaddeo D., Scaramozzino P., Autorino G.L. Active circulation of bluetongue vaccine virus serotype-2 among unvaccinated cattle in central Italy. Prev. Vet. Med. 2005, 68:103-113.
15. Hoffmann B., Eschbaumer M., Beer M. Real-time quantitative reverse transcription-PCR assays specifically detecting bluetongue virus serotypes 1, 6, and 8. J. Clin. Microbiol. 2009, 47:2992-2994.
16. Hoffmann B., Sasserath M., Thalheim S., Bunzenthal C., Strebelow G., Beer M. Bluetongue virus serotype 8 reemergence in Germany, 2007 and 2008. Emerg. Infect. Dis. 2008, 14:1421-1423.
17. Kirkland P.D., Hawkes R.A. A comparison of laboratory and 'wild' strains of bluetongue virus - is there a difference and does it matter?. Vet. Ital. 2004, 40:448-455.
18. Listes E., Monaco F., Labrović A., Paladini C., Leone A., Di Gialleonardo L., Cammá C., Savini G. First evidence of bluetongue virus serotype 16 in Croatia. Vet. Microbiol. 2009, 138:92-97.
19. MacLachlan N.J. Bluetongue virus vaccines: solution or part of the problem?. Proceedings of the International Meeting on Emerging Diseases and Surveillance 2009.
20. MacLachlan N.J., Nunamaker R.A., Katz J.B., Sawyer M.M., Akita G.Y., Osburn B.I., Tabachnick W.J. Detection of bluetongue virus in the blood of inoculated calves: comparison of virus isolation, PCR assay, and in vitro feeding of Culicoides variipennis. Arch. Virol. 1994, 136:1-8.
21. Martinelle L., dal Pozzo F., Sarradin P., de Leeuw I., de Clercq K., Ziant D., Thiry E., Saegerman C. Experimental infection of calves with BTV-8 using two different inocula. Proceedings of the 8th International Congress of Veterinary Virology 2009.
22. OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2009, Office International des Epizooties, Paris, France.
23. Savini G., Hamers C., Conte A., Migliaccio P., Bonfini B., Teodori L., Di Ventura M., Hudelet P., Schumacher C., Caporale V. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle. Vet. Microbiol. 2009, 133:1-8.
24. Savini G., MacLachlan N.J., Sánchez-Vizcaíno J.M., Zientara S. Vaccines against bluetongue in Europe. Comp. Immunol. Microbiol. Infect. Dis. 2008, 31:101-120.
25. Savini G., Ronchi G.F., Leone A., Ciarelli A., Migliaccio P., Franchi P., Mercante M.T., Pini A. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy. Vet. Microbiol. 2007, 124:140-146.
26. Toussaint J.F., Sailleau C., Bréard E., Zientara S., De Clercq K. Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments. J. Virol. Methods 2007, 140:115-123.
27. Veronesi E., Darpel K.E., Hamblin C., Carpenter S., Takamatsu H.H., Anthony S.J., Elliott H., Mertens P.P., Mellor P.S. Viraemia and clinical disease in Dorset Poll sheep following vaccination with live attenuated bluetongue virus vaccines serotypes 16 and 4. Vaccine 2010, 28:1397-1403.
28. Verwoerd D.W., Erasmus B.J. Bluetongue. Infectious Diseases of Livestock 2004, Oxford University Press, Cape Town, South Africa. J.A.W. Coetzer, R.C. Tustin (Eds.).
29. Worwa G., Hilbe M., Ehrensperger F., Chaignat V., Hofmann M.A., Griot C., Maclachlan N.J., Thuer B. Experimental transplacental infection of sheep with bluetongue virus serotype 8. Vet. Rec. 2009, 164:499-500.